Influenza (flu) and respiratory syncytial virus (RSV) are two distinct viruses that cause similar symptoms, peak during the same months, and often get confused for each other. Both spread through respiratory droplets, both cause fever and cough, and both circulate heavily between December and February. But they belong to entirely different viral families, affect different parts of the airways, and pose the greatest danger to different groups of people.
Two Different Viruses, Similar Symptoms
The flu is caused by influenza viruses, while RSV belongs to a separate viral family called Pneumoviridae. That distinction matters because the two viruses behave differently once inside your body. Influenza tends to attack the upper respiratory tract first, causing the sudden onset of fever, body aches, headache, and fatigue that most people recognize as “the flu.” RSV also starts with upper respiratory symptoms like a runny nose and cough, but it has a stronger tendency to move into the lower airways, particularly the small breathing tubes deep in the lungs.
The overlap in symptoms is what makes these infections so hard to tell apart without a test. Both can cause fever, cough, sore throat, runny nose, and general fatigue. A systematic review of diagnostic accuracy found that clinical signs alone aren’t reliable enough to distinguish between viral respiratory infections. Even doctors can’t consistently tell the difference at the bedside.
Who Gets Hit Hardest
Both viruses are most dangerous for older adults, young children, pregnant women, and people with weakened immune systems or chronic conditions like heart disease, lung disease, or diabetes. But the risks aren’t identical.
RSV is the leading cause of bronchiolitis and pneumonia in children under 1 year old. Bronchiolitis is an inflammation of the tiny airways in the lungs, and it can make breathing extremely difficult for infants whose airways are already small. Babies don’t have fully developed immune systems, and the combination of immature lungs and a virus that targets the lower airways makes RSV particularly threatening in this age group.
The flu, by contrast, tends to cause more widespread illness across all age groups. It can lead to pneumonia, but it also triggers complications outside the lungs, including sinus infections, ear infections, and in rare cases, inflammation of the heart or brain. Most deaths from respiratory viruses overall occur in adults over 65, with risk climbing sharply as age increases.
How They Spread and How Long They Last
Both viruses spread through respiratory droplets when an infected person coughs, sneezes, or talks. You can also pick them up by touching a contaminated surface and then touching your face. The flu has an incubation period of about one to four days, while RSV typically takes four to six days from exposure to first symptoms.
People with RSV are usually contagious for 3 to 8 days, and they can start spreading the virus a day or two before any symptoms appear. That pre-symptomatic spread is similar to the flu, where people can be contagious about a day before feeling sick. One important difference: some infants and immunocompromised individuals can shed RSV for four weeks or longer, even after their symptoms resolve. Flu viral shedding is generally shorter, typically lasting five to seven days in adults.
Seasonal Timing
Flu and RSV both circulate during fall and winter in the United States, and their seasons overlap significantly. Flu activity most often peaks in February, based on 40 years of CDC surveillance data, though December, January, and March peaks are also common. RSV season generally starts a bit earlier, often picking up in October or November, with peaks that can hit before or alongside the flu wave. During the heart of winter, both viruses circulate simultaneously, which is why some people, especially young children, can catch both around the same time.
Testing and Diagnosis
Because symptoms overlap so heavily, the only reliable way to know which virus you have is a test. Rapid tests for both flu and RSV are widely available in clinics and emergency rooms, delivering results in under two hours. These tests are highly specific, meaning a positive result is almost certainly correct (specificity around 99% for both viruses). However, they’re less sensitive, meaning they miss a fair number of true infections.
Rapid tests for RSV actually perform slightly better than those for flu, with an average sensitivity of about 75% compared to 61% for influenza. In other words, a rapid flu test misses roughly 4 out of 10 true flu cases, while an RSV rapid test misses about 1 in 4. When doctors need a more definitive answer, they use PCR-based tests, which are the gold standard for detecting respiratory viruses and are significantly more accurate, though results take longer.
Treatment Options
This is one of the biggest practical differences between the two. The flu has antiviral treatments that can shorten the illness and reduce the risk of complications if started within the first 48 hours of symptoms. These prescription medications work by blocking the virus from replicating and are recommended for people at high risk of severe illness.
RSV has no equivalent antiviral for most patients. Treatment is primarily supportive: rest, fluids, fever management, and in severe cases, supplemental oxygen or hospital care. For high-risk infants, a monoclonal antibody (nirsevimab) is available as a preventive injection that helps protect against severe RSV disease. An older option (palivizumab) has been used for years in premature infants and children with certain heart or lung conditions. Neither of these treats an active RSV infection the way flu antivirals treat influenza. They work by giving the immune system a head start before exposure.
Vaccines and Prevention
Flu vaccines have been available for decades and are updated annually to match circulating strains. They’re recommended for everyone 6 months and older each fall.
RSV vaccines are newer. The CDC recommends a single dose of RSV vaccine for all adults 75 and older, and for adults ages 50 to 74 who are at increased risk. The list of qualifying conditions is extensive: chronic heart disease, lung disease, diabetes with organ damage, severe obesity (BMI of 40 or higher), chronic kidney or liver disease, neurologic conditions that impair breathing, sickle cell disease, moderate to severe immune compromise, and residence in a nursing home. For infants, the monoclonal antibody injection serves a similar protective role, and a maternal RSV vaccine given during pregnancy can help protect newborns during their most vulnerable months.
For both viruses, basic prevention strategies are the same: frequent handwashing, avoiding close contact with sick individuals, and covering coughs and sneezes. These measures are especially important during the overlap period from November through February when both viruses are circulating at high levels.